Home
News
Create
Screeners
Insights
Smruthi Organics
117.
00
-0.95
(-0.81%)
Market Cap
₹133.91 Cr
PE Ratio
29.41
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-0.81%
1M
-0.89%
6M
-21.27%
1Y
+0.43%
5Y
-54.08%
View Company Insights
Latest news about Smruthi Organics
Smruthi Organics Receives CEP Certificate from EDQM for Amlodipine Besilate
8 days ago
Smruthi Organics Limited has successfully received a Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for its Amlodipine Besilate product. This achievement completes the regulatory approval process that began with a successful EU GMP compliance inspection at the company's Solapur facility. The CEP certification enables the company to supply Amlodipine Besilate to pharmaceutical manufacturers in European markets and other regions that recognize CEP certification, significantly strengthening its position in regulated markets.
Smruthi Organics Reports Q3 FY26 Results Following Board Meeting Approval
Feb 13, 2026
Smruthi Organics Limited Schedules Board Meeting on February 13, 2026 for Q3FY26 Results Approval
Feb 05, 2026
Smruthi Organics Reports Robust Q2 Recovery with Rs 205.62 Crore Net Profit
Nov 11, 2025
Smruthi Organics Reports Net Loss of Rs 109.54 Lakhs in Q1
Aug 13, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/ Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation
IPO